Click image to enlarge
Category: Outsourced Compounding Services (503B) (Click here to return)
Click here to request more information
RTA Intravenous Dexamethasone
QuVa Pharma, Inc
Click here to view supplier website
QuVa Pharma provides dexamethasone phosphate as a compounded sterile product in a ready-to-administer IV bag, now available for order under FDA Drug Shortage guidelines. This compounded sterile product (CSP) is available as 6 mg in 25 mL 0.9% sodium chloride IV bag. Updated recommendations for the COVID-19 Treatment Guidelines Panel from The National Institutes of Health and the World Health Organization Panel include systemic corticosteroids, like dexamethasone 6 mg daily, for hospitalized patients with severe and critical COVID-19.
QuVa Pharma, Inc
Entry published in PP&P January 2021